Page last updated: 2024-11-05

trifluperidol and Borderline Personality Disorder

trifluperidol has been researched along with Borderline Personality Disorder in 1 studies

Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)

Borderline Personality Disorder: A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Planche, R1

Other Studies

1 other study available for trifluperidol and Borderline Personality Disorder

ArticleYear
[Long-term use of 200 mg Dogmatil. Apropos of 13 cases].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1984, Mar-22, Volume: 60, Issue:13

    Topics: Adult; Amitriptyline; Antipsychotic Agents; Bipolar Disorder; Borderline Personality Disorder; Drug

1984